MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*Driving Forces: Risk Capital_Angel, Venture (VC), Strategic Corporate( CVC), Private Equity (PE), Mergers and Acquisition (M&A) (Facts & Figures)
Venture-Geographic Data
*Bioscience Regional Clusters & HotSpots
*Industry: Massachusetts
Synlogic, Inc. (NASDAQ: SYBX)
Organization & Developments: Synlogic
Parents
Synlogic, Inc. (NASDAQ: SYBX)
Children
*Synlogic is working at the intersection of biology and engineering, pioneering the application of synthetic biology to design living therapeutics programmed to treat disease in new ways.
*The company is focused on developing synthetic biotic medicines to treat metabolic, inflammatory, and cancer
2021: Sizing Up Synlogic
2022: Synlogic Announces Synthetic Biotic for Gout Developed in Partnership with Ginkgo Bioworks
2022: Synlogic Granted FDA Fast Track Designation for SYNB1353
2022: Synlogic succumbs to layoff pressure
2022: Synlogic, Ginkgo Bioworks develop SYNB2081 to treat gout
2024: Synlogic reaches end of line, laying off 90% of staff and ceasing operations after phase 3 fail
Jumps
Finance & Acquisitions: Synlogic
Key People: Synlogic